Yerkes researchers propose ambitious new strategies for AIDS vaccine research
Researchers at the Yerkes National Primate Research Center, Emory University, believe conventional vaccine strategies should not be the only avenue explored in the development of an effective AIDS vaccine. Based on studying simian immunodeficiency viruses (SIVs) in African nonhuman primates, they ...Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender
SHENZHEN, China, Aug. 7 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS:PK), ( http://www.htdsmedical.com ) subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significa...Many Texas Docs Not Pushing HPV Vaccine for Girls
Study finds fewer than half always recommend the shots, despite federal guidelines THURSDAY, Aug. 6 (HealthDay News) -- More than half of Texas doctors don't always recommend human papillomavirus (HPV) vaccination for girls, despite U.S. guidelines urging their inoculation, a new surv...BCBSGA Announces Decision to Cover H1N1 Vaccine Administration
ATLANTA, Aug. 3 /PRNewswire/ -- Blue Cross and Blue Shield of Georgia (BCBSGA) announced today that it will offer coverage for the administration of the H1N1 (swine flu) vaccine when it becomes commercially available to the general public. The vaccine administration will be covered for member...WellPoint Announces Decision to Cover H1N1 Vaccine Administration
INDIANAPOLIS, July 30 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP ) announced today that it will offer coverage for the administration of the H1N1 (swine flu) vaccine when it becomes commercially available to the general public. The vaccine administration will be covered for member...Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
LYON, France and SWIFTWATER, Pa., Aug. 7 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), announced today the company has submitted to the U.S. Food and Drug Administration (FDA) a supplemental application for licensure...Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
LONDON, July 7 /PRNewswire/ -- The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet . The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix (R) is highly effective at protecting against the two most common cervical cance...Novel Vaccine Approach Offers Hope in Fight Against HIV
--Gene Transfer Technology May Lead to an HIV Vaccine-- PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine dev...Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
Completion of enrollment keeps Company on track to report primary study results in third quarter of this year ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that enrollment has been completed in the second Phase II clinical trial of its trival...Anthrax Vaccine Immunization Program
... The Anthrax vaccine Immunization Program (AVIP), is the name of the po... and specific civilian personnel with the anthrax vaccine . It began in earnest in 1997 by the Clinton admi...mainly concerning the methods and viability of the vaccine manufactured by BioPort , a subsidiary of Emerge...Artificial induction of immunity
...es, Pasteur isolated the infectious agent from anthrax . He then derived a vaccine by altering the infectious agent so as to make it harmless and then introdu...ces are known as adjuvants . Several different adjuvants have been used in vaccine preparation. Adjuvants are also used in other ways in researching the immun...More than half of Texas physicians do not always recommend HPV vaccine to girls
PHILADELPHIA - The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent survey showed that more than half of Texas physicians do not follow these recommendations. The survey was published in Can...First genetically-engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year. Mala...Penn-Wistar team gains insight into HIV vaccine failure
PHILADELPHIA (July 20, 2009) A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines....LSUHSC's Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
New Orleans, LA Jay K. Kolls, MD, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans School of Medicine, has been awarded $1.8 million over five years by the National Heart, Lung and Blood Institute of the National Institutes of Health to study whether antibodies that re...UTSA infectious disease researchers advancing vaccine against Valley fever
San Antonio Medical mycologists in The South Texas Center for Emerging Infectious Diseases (STCEID) and the Department of Biology at The University of Texas at San Antonio (UTSA) have significantly advanced the fight against San Joaquin Valley Fever, a respiratory infection of humans, commonly ca...ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, has signed an agreement with UK-based Scancell Ltd., the operating company of Scancell Holdings Plc (SCLP.PL), which is developing therapeutic cancer and infectious disease vaccines. T...Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers received their first shot of the vaccine and, during the thr...Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during th...First genetically engineered malaria vaccine to enter human trials
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year. Mala...GenVec Expands Contract Supporting Malaria Vaccine Program
GAITHERSBURG, Md., July 27 /PRNewswire-FirstCall/ -- Today GenVec, Inc. (Nasdaq: GNVC ) announced the expansion of an existing contract with the PATH Malaria Vaccine Initiative (MVI) to support the development of vaccines to fight malaria through MVI and USAID funding. This contract, valued...Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Description:...ouse monoclonal [YPF19] to Yersinia pestis This antibody is used to detect Yersinia pestis . Immunogen: Purified F1 antigen from Yersinia pestis vaccine strain EV76. Specificity: This antibody recognises Y.pestis F1 capsular antigen. There is no cross-reactivity with Y.pseudotuberculosis and Y. ente...Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone 1.F.1 from Abcam
Description:... Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....Custom Epitope Peptide Microarray from LC Sciences
Description:... Microarrays designed for immunological studies, vaccine development, and biosensor development built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are avail...Epitope Peptide Microarray - Comprehensive Service from LC Sciences
Description:...comprehensive epitope analysis service utilizing high density peptide microarrays synthesized on Paraflo microfluidic chips for immunological studies, vaccine development, and biosensor development. This comprehensive service includes assistance with your sequence designs, binding assays using sample(s) prov...